Autolus Therapeutics plc
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 375.6% | 100.0% | 17.9% | – | – | 476,910.3% | 199.9% | 116.8% | 135.1% | 104.3% | 93.7% | 44.8% | 84.3% | |
| -275.6% | -100.0% | 82.1% | – | – | -476,810.3% | -99.9% | -16.8% | -35.1% | -4.3% | 6.3% | 55.2% | 15.7% | |
| 7,960.1% | 1,417.4% | 303.9% | – | – | 174,241.4% | 297.6% | 131.1% | 131.6% | 146.7% | 80.9% | 61.1% | 95.9% | |
| 2,613.5% | 886.1% | 180.1% | – | – | 232,448.3% | 328.8% | 144.6% | 171.2% | 147.6% | 152.4% | 90.1% | 130.5% | |
| 10,573.6% | 2,203.4% | 466.2% | – | – | 355,693.1% | 626.5% | 275.7% | 302.8% | 294.1% | 233.3% | 151.2% | 226.4% | |
| -10,849.3% | -2,303.4% | -384.1% | – | – | -832,503.4% | -726.3% | -292.6% | -337.9% | -298.3% | -227.0% | -95.9% | -210.8% | |
| 1,235.0% | 1,697.4% | 191.0% | – | – | 106,327.6% | 112.9% | 32.6% | 49.6% | 94.0% | 42.4% | 5.9% | 40.1% | |
| -11,298.0% | -3,651.3% | -522.2% | – | – | -90,151.7% | -756.4% | -227.1% | -370.8% | -376.8% | -269.8% | -84.6% | -238.0% | |
| -5.2% | 696.4% | -0.1% | – | – | 5,041.4% | 24.8% | 1.9% | 2.5% | -4.9% | 3.3% | 1.0% | 0.6% | |
| -11,292.9% | -4,347.7% | -522.1% | – | – | -95,193.1% | -781.1% | -229.0% | -373.3% | -371.9% | -273.1% | -85.6% | -238.6% | |
| -10,134.0% | -1,853.9% | -313.4% | – | – | -254,437.9% | -618.1% | -206.5% | -305.3% | -271.9% | -217.2% | -74.0% | -188.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.